Global Compounding Pharmacy Market

Global Compounding Pharmacy Market Size, Share, Growth Analysis, By Product(Medications, Topical medications), By Therapeutic Area(Hormone replacement therapies, Pain medications) - Industry Forecast 2024-2031


Report ID: SQMIG35I2094 | Region: Global | Published Date: April, 2024
Pages: 157 | Tables: 64 | Figures: 75

Global Compounding Pharmacy Market Regional Insights

North America compounding pharmacy market share is expanding at a consistent rate. High disposable income among the people in North America has driven the developments in the healthcare industry due to the affordability to invest in highly advanced medication that meets the targeted medical needs of the people.

The expanding healthcare infrastructure in the Asia Pacific is expected to drive the region's growth at a significant CAGR. The market for compounding pharmacies in the Asia Pacific area will also grow due to an increase in research and development activities aimed at enhancing various healthcare outcomes and obtaining more exact and accurate findings. The rise in the geriatric population and rates of chronic diseases would also put more pressure on the healthcare system and boost the market during the forecast period.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Compounding Pharmacy Market size was valued at USD 8.12 billion in 2019 and is poised to grow from USD 8.62 billion in 2023 to USD 14.82 billion by 2031, growing at a CAGR of 6.2% in the forecast period (2024-2031).

The Global compounding pharmacy market is highly fragmented, with a high level of competition. The prominent players operating in the market such as nature. B. Braun, Athenex Pharma Solutions, Fresenius Kabi, Clinigen Group PLC, Dougherty's Pharmacy, Inc., Lorraine’s Pharmacy, Nephron Pharmaceuticals Corporation To maintain market rivalry, these leading industry firms strategically implement several inorganic growth tactics like mergers and acquisitions. 'B. Braun Melsungen AG', 'Fagron NV', 'PharMEDium Services LLC', 'Fresenius Kabi AG', 'Becton, Dickinson and Company', 'McGuff Compounding Pharmacy Services Inc.', 'Wedgewood Pharmacy', 'Village Compounding Pharmacy', 'Dougherty's Pharmacy, Inc.', 'Institutional Pharmacy Solutions', 'Pencol Compounding Pharmacy', 'Lorraine's Pharmacy', 'Triangle Compounding Pharmacy', 'Custom Med Apothecary', 'The Compounding Center', 'Letco Medical', 'Lee Silsby Compounding Pharmacy', 'Olympia Pharmacy', 'Precision Compounding Pharmacy', 'College Pharmacy'

Increased oral medication use is major opportunities for market expansion.

The market for compounding pharmacies is expected to grow as a result of increased topical formulation research and development. Topical formulations including gels, creams, ointments, and other such products are highly sought-after. Pharmaceutical companies are focusing their efforts on R&D to create ground-breaking topical formulations. These elements are therefore expected to fuel market expansion in the near future.

North America compounding pharmacy market share is expanding at a consistent rate. High disposable income among the people in North America has driven the developments in the healthcare industry due to the affordability to invest in highly advanced medication that meets the targeted medical needs of the people.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Compounding Pharmacy Market

Product ID: SQMIG35I2094

$5,300
BUY NOW GET FREE SAMPLE